Heart Failure After Heart Transplantation Due to Chronic Rejection
NCT ID: NCT03808324
Last Updated: 2019-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2019-01-31
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Heart Transplant Rejection
NCT00042614
Noninvasive Evaluation of Cardiac Allograft Vasculopathy
NCT01305382
Effects of Renal Transplantation on Uraemic Cardiomyopathy
NCT03892343
A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
NCT03477383
Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing
NCT01833195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart transplant recipients
Diagnostic investigations
Participants will undergo tests and diagnostics investigations to identify signs of chronic rejection after heart transplantation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic investigations
Participants will undergo tests and diagnostics investigations to identify signs of chronic rejection after heart transplantation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled yearly post-transplant control
* Signed informed consent
Exclusion Criteria
* Radiographic contrast allergy
* Severe asthma or COLD with FEV1 \< 50%
* Second or third degree AV block
* Pregnancy
* In the Investigator's opinion, the patient has a clinically significant disease that could be adversely affected by study participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sorosh Esmaily
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AVALON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.